Jim Cramer says to hold on to these 3 cloud stocks and sell the rest

Jim Cramer says to hold on to these 3 cloud stocks and sell the rest


Cramer on cloud computing stocks' run on Thursday

CNBC’s Jim Cramer on Friday offered a list of stock picks for investors who are bullish on cloud computing but cautioned that he believes there’s more pain to come.

“I recommend using this incredible rebound actually as a rare opportunity to sell the weaker cloud stocks into strength,” he said. “That said, some of them might be worth keeping, but only the highest quality names.”

Here is his list of keepers:

  1. CrowdStrike
  2. Datadog
  3. ServiceNow

Honorable mentions, which he likes but doesn’t necessarily recommend buying, include Salesforce and Workday.

To come up with his list, Cramer first looked at the WisdomTree Cloud Computing Fund, an ETF that soared over 13% on Thursday after the October consumer price index came in lighter than expected.

Cramer first narrowed the list of 75 stocks in the exchange-traded fund by eliminating companies with these qualities:

  1. Has a market capitalization below $1 billion
  2. Is expected to be unprofitable next year
  3. Is only tangentially related to the cloud
  4. Doesn’t pass the rule of 40 test, meaning the sum of its revenue growth and profit margin is less than 40%

That left him with 13 stocks, and he picked his three favorites.

Cramer maintained that while he likes the stocks he picked, investors should take the chance to exit their cloud stocks while they’re up. If you were trapped in these things, this is giving you a chance to get out,” he said.

Disclaimer: Cramer’s Charitable Trust owns shares of Salesforce.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More
Used vehicle prices jump ahead of spring selling season optimism
Business

Used vehicle prices jump ahead of spring selling season optimism

A used car dealership is seen in Annapolis, Maryland on May 27, 2021, as many car dealerships across the country are running low on new vehicles as a computer chip shortage has caused production at many vehicle manufactures to nearly stop. Jim Watson | AFP | Getty Images DETROIT — A closely watched barometer for used […]

Read More